The current significance and prospects for the use of dual receptor agonism GLP-1/Glucagon
Renata Spezani, Carlos Alberto Mandarim‐de‐Lacerda
Topics & Concepts
MedicineAdverse effectGastric emptyingAgonismPharmacologyGlucagonGlucagon-like peptide-1Type 2 Diabetes MellitusOverweightDiabetes mellitusInsulinType 2 diabetesEndocrinologyInternal medicineObesityStomachLawPoliticsPolitical scienceDiabetes Treatment and ManagementPharmacology and Obesity TreatmentMetabolism, Diabetes, and Cancer